Northwestern Mutual Wealth Management’s Sinovac Biotech, Ltd SVA Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio SVA Stock Details SVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$0	Buy	+1,000	New	–	﹤0.01%	4539
2023 Q4	–	Sell	-102	Closed	-$660	–	3749
2023 Q3	$660	Sell	102 -6	-6%	-$39	﹤0.01%	3088
2023 Q2	$699	Buy	+108	New	+$699	﹤0.01%	3135
2022 Q4	–	Sell	-102	Closed	-$1K	–	3554
2022 Q3	$1K	Hold	102	–	–	﹤0.01%	3063
2022 Q2	$1K	Buy	+102	New	+$1K	﹤0.01%	3131
2022 Q1	–	Sell	-102	Closed	-$1K	–	3573
2021 Q4	$1K	Buy	102 +100	+5,000%	+$980	﹤0.01%	3104
2021 Q3	$0	Hold	2	–	–	﹤0.01%	3356
2021 Q2	$0	Hold	2	–	–	﹤0.01%	3257
2021 Q1	$0	Hold	2	–	–	﹤0.01%	3070
2020 Q4	$0	Hold	2	–	–	﹤0.01%	2987
2020 Q3	$0	Buy	+2	New	–	﹤0.01%	2770

Other funds holding SVA

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

NAH

Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Horizon Investments Charlotte, North Carolina $8.92B AUM 25.62% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Northwestern Mutual Wealth Management's SVA Position: Q1 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Sinovac Biotech, Ltd (SVA) in Q1 2026: 1,000 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #4539 among its holdings. This is a return to the name: Northwestern Mutual Wealth Management previously reported a position in SVA as recently as Q3 2023.

Northwestern Mutual Wealth Management first reported a position in SVA in Q3 2020 and has held it in 11 quarters since. The position peaked at $1K in Q3 2022. 28 funds tracked by Wall St. Rank hold SVA as of Q1 2026.

Northwestern Mutual Wealth Management held 1,000 shares of Sinovac Biotech, Ltd worth $0 as of Q1 2026.
Sinovac Biotech, Ltd was a new Northwestern Mutual Wealth Management position in Q1 2026.
Sinovac Biotech, Ltd made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #4539 holding.
Northwestern Mutual Wealth Management first reported a position in Sinovac Biotech, Ltd in Q3 2020 and has held it in 11 quarters since.
Northwestern Mutual Wealth Management's Sinovac Biotech, Ltd position peaked at $1K in Q3 2022.
28 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.